- April 24, 2020 - Visit our “At-A-Glance” resource summarizing the FDA COVID-19 Response
- April 23, 2020 - Daily Roundup
- April 23, 2020 - FDA Warns Companies Illegally Selling CBD Products to Treat Medical Conditions, Opioid Addiction
- April 23, 2020 - Update: Court Grants FDA’s Request for Extension of Premarket Review Submission Deadline for Certain Tobacco Products Because of Impacts from COVID-19
- April 22, 2020 - FDA Issues Temporary Policy for Certain Requirements under the Accredited Third-Party Certification Program During COVID-19 Public Health Emergency
- April 22, 2020 - Daily Roundup
- April 22, 2020 - FDA Approves New Therapy for Triple Negative Breast Cancer That Has Spread, Not Responded to Other Treatments
- April 22, 2020 - FDA Issues a Temporary Guidance for Industry on Repackaging or Combining Propofol Drug Products
|
No hay comentarios:
Publicar un comentario